Evidence map›Paper›PMID 39226374›Full record

ArticleScience signaling2024

Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3β.

Michael D Enos, Maire Gavagan, Noel Jameson, Jesse G Zalatan, William I Weis

Abstract read
In one paragraph

Article in Science signaling, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael D EnosDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94035, USA.ORCID 0000-0003-3208-7043
Maire GavaganDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-3986-6760
Noel JamesonDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0001-9231-3765
Jesse G ZalatanDepartment of Chemistry, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-1458-0654
William I WeisDepartment of Structural Biology, Stanford University School of Medicine, Stanford, CA 94035, USA.ORCID 0000-0002-5583-6150

Funding

A Synchrotron Radiation Structural Biology ResourcesP30GM133894 · NIGMS · STANFORD UNIVERSITY · PI Aina E. Cohen, KEITH O HODGSON · 2020 to 2026
$43.3M
Supplement to Enhance Wellness and Resiliency in the Graduate EnvironmentT32GM007276 · NIGMS · STANFORD UNIVERSITY · PI MORRISON, ASHBY J. · 1985 to 2023
$32.9M
Spatial Organization in Biochemical Reaction NetworksR35GM124773 · NIGMS · UNIVERSITY OF WASHINGTON · PI Jesse George Zalatan · 2017 to 2026
$3.9M
Molecular mechanisms of Wnt and mechanical signaling through β-cateninR35GM131747 · NIGMS · STANFORD UNIVERSITY · PI POKUTTA, SABINE · 2019 to 2023
$3.1M
Molecular Mechanisms of Wnt Signal TransductionR01GM119156 · NIGMS · STANFORD UNIVERSITY · PI WEIS, WILLIAM I · 2016 to 2019
$1.3M
NIGMS NIH HHS P30 GM133894NIGMS NIH HHS R01 GM119156NIGMS NIH HHS R35 GM124773NIGMS NIH HHS R35 GM131747NIGMS NIH HHS T32 GM007276
6 · The paper itself

Abstract

Glycogen synthase kinase 3β (GSK-3β) targets specific signaling pathways in response to distinct upstream signals. We used structural and functional studies to dissect how an upstream phosphorylation step primes the Wnt signaling component β-catenin for phosphorylation by GSK-3β and how scaffolding interactions contribute to this reaction. Our crystal structure of GSK-3β bound to a phosphoprimed β-catenin peptide confirmed the expected binding mode of the phosphoprimed residue adjacent to the catalytic site. An aspartate phosphomimic in the priming site of β-catenin adopted an indistinguishable structure but reacted approximately 1000-fold slower than the native phosphoprimed substrate. This result suggests that substrate positioning alone is not sufficient for catalysis and that native phosphopriming interactions are necessary. We also obtained a structure of GSK-3β with an extended peptide from the scaffold protein Axin that bound with greater affinity than that of previously crystallized Axin fragments. This structure neither revealed additional contacts that produce the higher affinity nor explained how substrate interactions in the GSK-3β active site are modulated by remote Axin binding. Together, our findings suggest that phosphopriming and scaffolding produce small conformational changes or allosteric effects, not captured in the crystal structures, that activate GSK-3β and facilitate β-catenin phosphorylation. These results highlight limitations in our ability to predict catalytic activity from structure and have potential implications for the role of natural phosphomimic mutations in kinase regulation and phosphosite evolution.

Indexed as

Axin Proteinbeta CateninGlycogen Synthase Kinase 3 betaCatalytic DomainCrystallography, X-RayHumansModels, MolecularPhosphorylationProtein BindingProtein ConformationWnt Signaling PathwayAxin Proteinbeta CateninGlycogen Synthase Kinase 3 betaGSK3B protein, human

Identifiers

PMID39226374
PMCPMC11461088

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.